Abstract. Phenotypically altered C2 myoblast cells, generated by the stable transfection of human nonmuscle actin genes (Schevzov, G., C. Lloyd, and P. Gunning. 1992. J. Cell Biol. 117:775-786), exhibit a differential pattern of tropomyosin cellular organization and isoform gene expression. The/~-actin transfectants displaying a threefold increase in the cell surface area, showed no significant changes in the pattern of organization of the high Mr tropomyosin isoform, Tm 2, or the low Mr tropomyosin isoform, Tm 5. In contrast, the 3'-and Bsm-actin gene transfectants, exhibiting a twofold decrease in the cell surface area, had an altered organization of Tm 2 but not Tm 5. In these actin transfectants, Tm 2 did not preferentially segregate into stress fiber-like structures and the intensity of staining was greatly diminished. Conversely, a welldefined stress fiber-like organization of Tm 5 was observed. The pattern of organization of these tropomyosin isoforms correlated with their expression such that a profound decrease in Tm 2 expression was observed both at the transcript and protein levels, whereas Tm 5 remained relatively unchanged. These results suggest that relative changes in nonmuscle actin gene expression can affect the organization and expression of tropomyosin in an isoform specific manner. Furthermore, this apparent direct link observed between actin and tropomyosin expression suggests that nonpharmacological signals originating in the cytoskeleton can regulate cytoarchitectural gene expression.
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T
HE ability of eukaryotic cells to adopt a variety of shapes and to carry out coordinated and directed movements depends on the cytoskeleton. Many of the components that constitute the cytoskeleton of nonmuscle ceils belong to a multigene family (Buckingham and Minty, 1982) . The presence of distinct but yet similar cytoskeletal isoforms arising from different genes presumably enables a cell to carry out diverse cellular processes such as cell motility, organelle and chromosome movement, cytokinesis, and the generation of cell shape. At present, however, the biological significance of these multiple contractile protein isoforms is still not fully understood.
In an attempt to address the question of isoform function we have stably transfected human nonmuscle actin genes into a mouse myogenic cell line . We observed that elevated expression of either the/~-or v-actin genes resulted in cells which displayed reciprocal changes in the overall surface area of the ceils. Correlated with these changes in cell morphology was a dramatic change in the organization of the actin microfilament network. Additionally, elevated expression of a mutant form of the/~-actin gene, one C. Lloyd's current address is Howard Hughes Medical Institute Research Laboratories, University of Chicago, Chicago, IL 60637.
Please address all correspondence to P. Gunning, Cell Biology Unit Children's Medical Research Institute, Locked Bag 23, Wentworthville, NSW, 2145, Australia. that codes for a stable but aberrant actin protein (/~m), resulted in cells which displayed a phenotype similar to that of the 3¢-actin transfectants.
The studies presented here were designed to elucidate the possible mechanisms by which/$-and 3,-actin may elicit the observed changes in cell shape and cytoarchitecture. Earlier studies have shown that different cell types have unique/~:~/ ratios (Otey et al., 1987) coupled with distinct cytoarchitectures. Analysis of our actin transfectants had revealed that changes in the relative expression of/$-and 3,-actin had occurred such that different/~:'t mRNA and protein ratios were observed . Consequently, is an alteration in the composition of/~-and 3,-actin alone sufficient to alter cell shape or is a change in the composition of other cytoskeletal components also required? Previous observations have demonstrated that a correlation exists between morphological changes and the expression of tropomyosin, a cytoskeletal component that closely associates with actin microfilaments. For example, morphological alterations coupled with changes in the pattern of tropomyosin gene expression is a general feature of oncogenic transformation (Cooper et al., 1985; Hendricks and Weintraub, 1984; Matsumura et al., 1983) . In addition, in vitro cellular differentiation has also been demonstrated to result in cell shape changes accompanied by changes in the expression of particular tropomyosin isoforms (Ben-Ze'ev et al., 1989) .
Tropomyosins are rod-shaped dimeric molecules that lie head-to-tail along the groove of actin filaments (Smillie, 1979) . At present it is known that in skeletal muscle tropomyosin mediates the calcium-ion dependent regulatory effect of the troponin complex on actomyosin ATPase activity, thereby bringing about contraction of the muscle (Huxley, 1972) . The biological function of this protein in nonmuscle cells still remains unclear. The observation that tropomyosin can stabilize actin filaments suggests that tropomyosin may play a structural and/or regulatory role in the organization of microfilaments and may ultimately regulate cell shape (Wegner, 1982; Bernstein and Bamburg, 1982) . The work of Liu and Bretscher (1989) strongly suggests that this may be the case. In yeast, disruption of a tropomyosin gene results in reduced growth rate, heterogeneity in cell size, and most importantly disruption of actin cables. In mammals at least five different nonmuscle tropomyosin isoforms have been identified. The high Mr tropomyosin isoforms (Matsumura and Yamashiro-Matsumura, 1985) are 284 amino acids in length, have apparent molecular masses on SDS-polyaerylamide gels of 40, 36.5, and 35 kD and are commonly known as Tm 1, 2, and 3, respectively. The low Mr tropomyosins are 248 amino acids in length, have apparent molecular masses of 32.4 and 32 kD and are commonly known as Tin 4 and 5, respectively (Matsumura et al., 1983) . Recently two more 248 amino acid tropomyosins, Tm 5a and 5b, have been found in rat fibroblasts (Lees-Miller et al., 1990) . These different isoforms are encoded by a multigene family and in mammals four tropomyosin genes have been characterized. In nonmusele cells the/~-Tm gene encodes Tm 1 (MacLeod et al., 1985; Helfman et al., 1986) ; o~-Tmf gene encodes Tm 2, 3, 5a and 5b (Wieczorek et al., 1988; Goodwin et al., 1991) ; and the Tm 4 gene encodes Tm 4 (MacLeod et al., 1987; Yammawaki-Kataoka and Helfman, 1987) . The fourth gene termed hTm,m by Reinach and MacI.ex~ (1986) also known as the otTms gene by Gunning et al. (1990) since the muscle product of this gene is preferentially expressed in slow twitch skeletal muscle, codes for Tm 5, also known as fibroblast TM30,m (Clayton et al., 1988) . The Tm.m gene has until recently only been characterized in humans, however, a recent report by Takenaga et al. (1990) demonstrates that the equivalent gene exists in rodents.
In an attempt to understand the morphological changes observed in our actin transfectant clones, we have investigated the cellular organization of two different tropomyosin isoforms by immunofluorescence. We also examined the expression of nonmuscle tropomyosin isoforms using isoform specific eDNA probes. We have found isoform specific changes to tropomyosin organization and gene expression in the different actin gene transfectant clones suggesting that a feedback regulatory mechanism exists for cytoskeletal organization and gene expression of its components.
Materials and Methods

Cell Culture and Transfection
Actin transfectants were generated by the stable transfection of human nonmuscle aodn genes into mouse C2 myoblasts as previously described in Schevzov et ai. (1992) . In brief, ~20 clones from each transfection were randomly selected. All these clones were analyzed for expression of the exogenous nonmuscle actin genes and only those expressing the exogenous gene at a significant level were chosen for further morphological and biochemical assays.
Immunofluorescence Staining
Cells were seeded on collagen-(Caif Skin Collagen, Caibiochem., Alexandria, NSW, Australia) coated glass slides for 24 h before fixing and permeabilizing in 1% formaldehyde followed by -20°C methanol. Nonspecific binding on slides was blocked by incubation at 37°C in PBS containing 10% FCS. Antibody incubations were carried out at 37°C for 2 h. Slides were washed extensively in PBS between antibody incubations and finally mounted with 1,4-Diazabicyclo[2.2.2]octane (Sigma Chem. Co., St. Louis, MO). Cells were examined and photographed on a Zeiss epifluorescence microscope with a 40x objective 0.75 NA. Photographs were taken with Kodak T-Max 400 ASA film, developed with D-76, and printed on Agfa b/w paper. For matched pairs of double-labeled cells, exposure times for photography and printing were identical.
Antibodies
The Tin 5 mAb used at 1:1,000 dilution was provided by Drs. J. J.-C. and J. L.-C. Lin and characterized in chicken tissues in Lin et al. (1985a) and in human EJ bladder carcinoma cells in Linet ai. (1988) . The TM311 mAb used at 1:400 dilution was purchased from Sigma Chem. Co., St Louis, MO. The rabbit antibody which specifically recognizes the Bm-actin protein (anti-asp) used at 1:50 dilution was provided by Dr. U. Aebi (~itt et al., 1987a) . The goat anti-mouse Ig's (G + L) FITC and goat anti-rabbit IgG rhodamine were purchased from ~go Inc. (Burlingame, CA).
One and Two-Dimensional Gel Electrophoresis and Western Transfer
Total cellular protein was isolated from 30% confluent cells grown in 100-ram plastic dishes. Samples were adjusted to equal protein concentrations by the method of Lowry et al. (1951) and electrophoresed on 12.5% SDS-PAGE gels according to Laemmll (1970) followed by Western blotting according to Towbin et al. (1979) . Antibody binding was visualized by incubation with 1:250 dilution of a mouse Ig 35S-labeled antibody (Amersham Australia, North Ryde, NSW, Australia) followed by exposure to Kodak XAR film (Kodak, North Ryde, NSW, Australia) for 1 d or goat anti-mouse alkaline phosphatase (Sigma Chem. Co.). The resulting autoradiographs were scanned using a Model 300 series computing densitometer (Molecular Dynamics, Inc., Sunnyvale, CA). To correct for any loading discrepancies, duplicate gels were run concurrently and one stained with Coomassie brilliant blue. The levels of protein of each tropomyosin isoform were expressed as a percentage of that seen in the control cells which was set to 100%. Twodimensional gel electrophoresis was performed essentially as described (Lin et al., 1988) with the first dimension containing pH 4-6 amphollnes and the second dimensional slabs containing 12.5 % acrylamide and 0.104% bis-acrylamide.
D NA Probes
Human Nonmuscle Act/n. Probes specific for the human ~-and 3,-actin mRNAs and which do not crosshybridize with the mouse mRNAs, pHFflA-3'UT-HH and pI-IFvA-3~JT-HX, have been characterized previously (Ng et al., 1985; Erba et ai., 1986) . These DNA fragments were used to measure the level of expression of the transfected human gene in all the mouse C2 clones relative to that in a human myoblast sample. Tm 2 and 3. A probe specific for Tm's 2 and 3 (pR~xTm-lA) was generated by PCR DNA amplification by Dr. R. Weinberger (Weinberger et ai., 1992) . The entire exon la and 79bp of 5'UTR from the rat .-Tmf gene was amplified using the following oligonucleotides 5'GTG GAT CCG CTC GC.A CTC CGG CTC TGC CAC 3' and 5' GGT AGA CGC AGA CCT GCT TGC 3' (Lees-Miller et al., 1990) . Amplification was carried out using rat genomic DNA. This probe detects only the 2.0-kb transcript and does not hybridize to the Tm 5a and 5b transcripts also produced by the same gene ( c~-Tmf).
Tm 5a and Jb. A probe specific for Tm 5a and 5b (pRaTm-lB) was generated by PCR DNA amplification by Dr. R. Weinberger (Weinberger et ai., 1992) . The entire exon lb and 78bp of 5'UTR from the rat o~-Tmf was amplified using oligonucleotides 5' GC~ TCC GTA ACT GCA GGA GCC 3' and 5' ~ IU_K3 GTG GAT CCC TAA CGG 3' (Lees-Miller et al., 1990) . Amplification was carried out using rat genomic DNA. This probe detects a 2.0-kb transcript.
Tm J. The Tm 5 nonmuscle eDNA (pMMTm5) was isolated from a mouse macrophage eDNA library (Clontech Laboratories Inc., Paio Alto, CA). The library was screened with a 32p-labeled cDNA fragment contain-ing the coding sequence for amino acids 213-284 and 48 bp of YUTR of the human a-Trr~ eDNA. Hybridization was in 4× SSC (1× SSC is 0.15 M NaCl, 0.015 M sodium citrate), 50 rnM NaI-I2PO4 (pH 7.0), 5× Denhardt's solution (Denhardt, 1966) at 65"C for 16 h, followed by three 30 rain washes in 0.5× SSC, 50 mM NaI-I2PO4 (pH 7.0), 0.1% SDS at 65"C. Partial sequence analysis of an isolated positive clone revealed that it is the mouse homologue of the human Tm 5 (Fig. 1, A and B) . Furthermore, the sequence obtained was identical to that of Takenaga et al. (Takenaga et al., 1990 , accession number X53753) which unambiguously demonstrates that it is the mouse Tm 5 nonmuscle isoform. The probe used for Northern blot analysis was generated by PCR amplification using the 5' primer 5' CCC TGC TC.d3 ACC TGA ACG AG 3' and the 3' primer 5' ACC CCG CAG TC.d2 AAC TGT TT 3' (denoted in Fig. 1 ). The reaction was performed with 100 ng of pMMTm5 and 1 t~g of each primer at an annealing temperature of 55°C. A 1,200-bp fragment was amplified corresponding to the entire YUTR of Tin 5 and which showed no identity to other Tm sequences (data not shown). This fragment was subcloned into the HinclI site of pGEM3Zf, to give the plasmid pMMTm5-YUT. This probe detects a 2.5-kb transcript in nonmuscle tissues.
DNA Sequence Analysis
DNA sequencing was carried out by the dideoxy chain termination method (Sanger et al., 1977) . Double stranded plasmid DNA was denatured to give single stranded DNA using 200 mM sodium hydroxide and 2 mM EDTA, and precipitated from ethanol plus sodium acetate and resuspended in water.
Northern Blots
Total cellular RNA was isolated from 30% confluent cells by the method described by Chomczynski and Sacchi (1987) . Total RNA was denatured and electrophoresed on 1% agarose gels containing 2.2 M formaldehyde and transferred to Hybond N+ (Amersham Australia, North Ryde, NSW, Australia) as described in Maniatis et al. (1982) . Probes were labeled by the random priming method (Feinberg and Vogelstein, 1983 ) and hybridized to RNA blots at 109 dpm//~g of DNA in a solution containing 4x SSC, 50 mM NaH2PO4 (pH 7.0), 5x Denhardfs solution (Denhardt, 1966) , and 10% (wt/vol) dextran sulfate at 650C for 16 h. After hybridization, the blots were washed at 65"C for 2 h in 0.5x SSC, 0.1% SDS. Filters were exposed to Kodak XAR film for 1-3 d. To verify that equivalent amounts of RNA were transferred, the RNA blots were hybridized to an 18S specific ribosomal RNA oligonucleotide probe under conditions of probe excess and washed at 55°C in 4x SSC, 0.1% SDS. Levels of mRNA were qnantitated by densitometry as described (Gunning et al., 1990) .
Results
Specificity of Tropomyosin cDNA Probes and Antibodies
Even though the work of Helfman and coworkers (Goodwin et al., 1991; Lees-Miller and Helfman, 1991) suggests that only three tropomyosin genes exist in rodents, Takenaga et al. (1990) have in fact cloned and characterized the mouse equivalent of the fourth human tropomyosin gene, Tram. This gene encodes the mouse nonmuscle Tm 5 protein which differs to the human Tm 5 (also known as TM30nm) by a single amino acid. In parallel, we also screened a mouse macrophage eDNA library with a eDNA fragment from the human o~Tm, eDNA (see Materials and Methods). Partial sequence analysis was performed on the YUTR of the clone obtained ( Fig. 1 A) . A comparison between our clone (pMMTm5) and that obtained by Takenaga et al. (Takenaga et al., 1990) unambiguously demonstrates that it is the mouse nonmuscle Tm 5 isoform. This clone which shares high homology to the human Tm 5 nonmusele isoform (Takenaga et al., 1990) differs from human Tm 4 (MacLex~ et al., 1987) and rat Tm 4 (Yamawaki-Kataoka and Helfman, 1987) . The probe used for subsequent Northern blot analysis was generated by PCR as described in Materials and Methods and the primers used are denoted in Fig. 1 A. Northern blot analysis using adult mouse tissues confirms that mouse Tm 5 has the expression pattern characteristic of a nonmuscle tropomyosin ( Fig. 
B).
The specificity of the two tropomyosin antibodies used in this study was determined on total cell extract isolated from Rat-l, C2 parental cell line, NIH-3T3, and a pUC18 transfected C2 clone. As illustrated in Fig. 2 A, the TM311 antibody recognizes two bands of size 40 and 36.5 kD corre- and d) . In the C2 and pUC18 transfected cells (Fig. 2 A,  lanes c and e) , the major protein recognized by the antibody is Tm 2. Two minor bands corresponding to Tm 1 and 3 are also detected in these samples if the immunoblot is overdeveloped or overloaded. No reaction is seen with Tm 4 and Tm 5 (32.4 and 32 kD) despite the expression of all these tropomyosin isoforms in C2 cells (Gunning et al., 1990) . The Tm 5 antibody (CG3) previously characterized by Lin et al. (1988) and found to detect only the "I'm 5 isoform in human EJ bladder carcinoma cells is shown to detect only one band of 32 kD in a pUC18 transfected cell extract (Fig.  2 B, lane b) . Since Tm 4 and Tm 5 appear to migrate to the same position in SDS-PAGE gels, the cross-reactivity of this antibody to Tm 4 cannot be determined from one-dimensional gel electrophoresis. To address this issue, two-dimensional gel analysis was performed to unambiguously demonstrate that this antibody does not cross-react with Tm 4. As shown in Fig. 3 B the Tm 5 antibody detects only one isoform. To demonstrate that the different tropomyosin isoforms were effectively separated, the same Western blot was reprobed with the Sigma Chem. Co. TM311 antibody. As shown in Fig. 3 , C and D, overexposure of the TM311 antibody reveals a clear separation of Tm's 1, 2, 3, and 6. Therefore, we can conclude that the Tm 5 antibody does not crossreact with Tm 4. There is, however, a formal possibility that this antibody may cross-react with Tm 5a and 5b. To assess the potential contribution ofTm 5a + 5b, we have hybridized the ot-Tmf gene exon la (see Tm 2 + 3) and exon lb (see Tm 5a + 5b) probes in parallel to identical filters containing C2 cell RNA. We observed only trace hybridization of the IB probe and estimate that the level of Tm 5a + 5b mRNA is <5 % of that of Tm 2 + 3 (data not shown). Consequently, we expect that subsequent cellular organization studies performed with this antibody will give a pattern of tropomyosin organization that corresponds predominantly to Tm 5.
Cellular Organization of Tropomyosin Isoforms in the Actin Transfectants
The cellular organization of tropomyosin was investigated in the different actin transfectants using the two distinct tropomyosin antibodies described above. Actin transfectant clones exhibiting the highest level of expression of the exogenous actin genes were chosen for the following studies because these cells showed the most severe phenotypic changes . The control cells used are C2 myoblasts transfected with a triple mutant form of the human /~-actin gene (~"), previously shown to cause no detectable changes in cell morphology or the actin microfilament network . Immunofluorescence staining revealed that the highest expressing/3, clone (~,-33) displayed a stress fiber-like organization of both ~ 2 and Tm 5 (Fig. 4, a and b) . The observed organization of tropomyosin is the same as that seen by Lazarides (1975) and Lin et al. (1988) in other nonmuscle cell types. Similarly, the highest expressing/~,~ clone (B~t-ll) also showed a stress fiber-like organization of Tm 2 and Tm 5 (Fig. 4, c and d) . However, a diffuse organization of Tm 2 was consistently observed in the highest expressing 7-actin clone ('y33-B1) (Fig.  4 e) as compared to the control cells (photo a). In contrast, the 3,33-B1 cells displayed highly visible stress fiber-like organization ofTm 5 (Fig. 4f) . This indicates that actin transfectants which display different morphologies may also show a differential pattern of tropomyosin organization.
Elevated expression of the B,= gene has previously been found to elicit a similar phenotype to that of the 3,-actin transfectants. This includes reduced surface area and diffuse organization of the actin cables . These similarities also extend to the pattern of expression of the endogenous actin genes . Do cells that exhibit similar alterations in their morphologies and actin stress fiber organization also show common changes in tropomyosin isoform cellular organization and expression7
The highest expressing B,m clone (B,m-22) displayed a diffuse organization of Tm 2 (Fig. 4 g ) similar to that observed in the "y33-B1 cells (Fig. 4 e) . Conversely, as in the case of the high expressing 7-actin transfectants, "y33-B1, a stress fiber-like organization of Tm 5 staining was observed in many B,m-22 cells.
Thus, the impact of high level expression of the/3,=-actin gene on Tm 2 and Tm 5 organization parallels that seen with the introduced ~,-actin gene, but differs from that in the high expressing B~ transfectants and the control cells. Hence, elevated expression of two distinct actin genes (B,m and 7-actin) which lead to similar changes in morphology and actin cable organization are also found to elicit similar changes in the cytoskeletal organization of Tm 2 but not Tm5.
Expression of the B,, and .y-actin Genes Leads to Significant Changes in the Intensity of Tropomyosin Staining
The/3m-22 and "f33-B1 cells displayed a substantial reduction in the intensity ofTm 2 but not Tm 5 immunofluorescent staining (Fig. 4) . To visualize this differential staining intensity, C2 parental cells were cocultured with either the ~,m" 22 or the ~y33-B1 cells. The/~,m-22 cells could be discriminated from the C2 parental cells by immunofluorescent staining with the antibody specific for the aberrant /~m-actin protein (anti-asp, Leavitt et al., 1987a) . Consequently, the cells were reacted with both the anti-asp and either the Tm 2 or the Tm 5 antibody. The use of two different secondary antibodies, goat anti-rabbit rhodamine to detect the antiasp and anti-mouse FITC to detect the Tm 2 or the Tm 5 allowed us to make a direct comparison of staining intensity on the same microscopic field. As illustrated in Fig. 5 , the cells which stained for the aberrant /3,m protein, photo a, show negligible staining for Tm 2, photo b, as compared to the control cells present in the same field. In contrast, Tm 5 staining intensity was equivalent in the fl~m expressing cells and control C2 cells (Fig. 5 compare c and d) . A similar observation was made with cocultures of C2 parental cells and 3,33-B1 cells. In this case the detection of the "y-actin transfectants was based on their morphology and cytoarchitecture (data not shown). In light of these results, we conclude that differential expression at the protein level of Tm 2 and Tm 5 may occur in these actin transfectants.
Distinct Expression of Tropomyosin Isoforms in the Actin Tmnsfectants
It is conceivable that the decrease in intensity observed with the Tm 2 antibody might be due to epitope blocking in the /3sm and "y-actin cells. To eliminate this possibility, the steady-state level of Tm 2 protein was determined by SDS-PAGE gel electrophoresis followed by immunoblotting (Fig.  6 ). Densitometric scans of the immunoblot revealed that in the B.m-22 and 733-B1 cells, Tm 2 was decreased by fivefold and fourfold, respectively, whereas the B,~-ll cells showed no significant changes in Tm 2 levels as compared to the control cells (/3~-33). We conclude, therefore, that the oh-served decrease in the immunofluorescence staining intensity of Tm 2 in the/~-22 and "t3rB1 cells corresponds to a decrease in the steady-state protein level.
The changes in protein content parallel changes in the level of mRNA accumulation. Since the highest expressing clone from each of the actin transfectants has been shown to elicit the most severe phenotypic changes, tropomyosin mRNA levels were initially analyzed in these clones. The levels of tropomyosin transcript accumulation in the B~-33, /~-11, "y3rB1, and/3s,-22 cells (expressed as a percentage of that found in a pUC18 transfected cell), were determined by the statistical analysis of mRNA values obtained from multiple Northern blot determinations (Table I ). In the/3~-33 cells no change in the level of expression of Tm 2, 3 was observed (Table I ). An unexpected result was the downregulation in Tm 5 transcript levels. It appears that the presence of an extra actin transcript coding for an unstable protein can impact on Tm 5 expression at the mRNA level. The highest expressing /~, transfectant, B~,-ll, revealed an increase in mRNA levels for the tropomyosin isoforms studied (Table I ). This is interesting since no changes in the protein levels of Tm 2 occurred (103 :t: 15; n = 2). One possible explanation for this discrepancy between protein and mRNA levels could simply be due to the fact that the antibody only detects Tm 2 protein, whereas for the transcript data the probe used detects both Tm 2 and Tm 3 transcript. Hence, the increase in transcript may be due to the contribution from Tm 3. In contrast, the 3wt-ll 151 + 18 n = 2 128 + 3 n = 2 3sm-22 12 + 1 n = 4 154 5:31 n = 4 "r33-B1 11 +0.6 n = 4 82 + 10n = 3
The level of transcript accumulation of the different Tm isoforms was determined in the highest expressing actin transfectants from independent RNA isolations. The mRNA values are expressed as a percentage of that found in a pUC18 transfeeted clone (pUC-A) which was set to 100% and are represented as a mean + SD. * n denotes the number of RNA isolations.
~33-B1 and/~,m-22 cells revealed a decrease in transcript accumulation of Tm 2, 3 but not Tm 5 (Table I) . For these transfectants, the immunofluorescence staining intensity and steady-state protein levels coincide with the observed changes in Tm 2 and Tm 5 mRNA levels. Subsequent analysis of tropomyosin expression was performed on actin transfectant clones which expressed the exogenous actin genes at different levels. This enabled the evaluation of the relationship between tropomyosin and exogenous actin gene expression.
Northern blots were quantitated by densitometry and the results are depicted graphically. Linear regression analysis was performed on the data points to determine if significant linear relationships exist between the levels of expression of the transfected actin genes and that of the tropomyosin isoforms. Elevated expression of the B~ gene resulted in no changes in the mRNA levels of Tm 2, 3 (Fig. 7 A) , whereas a decrease in Tm 5 was observed (Fig. 7 B) . These results were confirmed by regression analysis which demonstrated that no linear relationship was found to exist between the level of the human B~ gene expression and Tm 2, 3 (R = 0.57, p > 0.1) mRNA levels. Surprisingly, a linear relationship was found to exist between/3~ gene expression and Tm 5 mRNA levels (R = 0.95, p < 0.01) suggesting that expression of the h u m a n /~ gene progressively affected Tm 5 expression.
The impact of elevated expression of the human wild-type B-actin gene on the levels of tropomyosin isoform mRNAs is depicted graphically in Fig. 7 , C and D. No linear relationship was found to exist between the levels of human B,~ gene expression and Tm 2, 3 (R = 0.66, p < 0.1). The low expressing B~ transfectants showed a heterogeneous response in Tm 2, 3 transcript levels, and a substantial increase in Tm 2, 3 transcript levels was found to occur only in the highest expressing B,~ transfectant, B,~-ll (Table I ). In the case of the low M, tropomyosin isoform (Tm 5) no linear relationship was found to exist between the levels of human B~ gene expression and Tm 5 (R = 0.67, p < 0.1).
Impact of expression of the human -y-actin gene on the levels of tropomyosin isoform mRNAs is depicted graphically in Fig. 8, A Figure 7 . Expression of nonmuscle tropomyosin mRNAs in the Btm and 3,t-actin transfectants. Total cellular RNA was isolated from four Btm and six B,t-actin transfectants, having different levels of expression of the exogenous gene. 3 #g of RNA from each clone was size fractionated and hybridized with the tropomyosin isoform specific probes Tin 2, 3 (pRc~Tm-lA) and Tm 5 (pMMTm5-3%IT) as described in Materials and Methods. The Northern blots were subsequently probed for 18S ribosomal RNA and corrected for loading discrepancies. The autoradiograms were quantitated by densitometry and the results are presented as graphs. The mRNA values for the different tropomyosin isoforms are expressed as a percentage of that seen in a control cell (pUC18 transfected C2 cells) which was set to 100%. The values for the human exogenous gene are expressed relative to that seen in a human myoblast RNA sample. Graphs A and B correspond to/3tm transfeetants and graphs C and D correspond to B~t transfectants. Linear regression analysis was performed on the data points and the resulting line is shown on each graph.
regulation of a tropomyosin gene that encodes the high Mr tropomyosin isoforms, Tms 2 and 3. These results are in agreement with the observed decrease in the staining intensity and steady-state protein levels of Tm 2 in the 733-B1 cells (Fig. 6, lane 4) . In terms of the low Mr tropomyosin isoform, no linear relationship occurred for Tm 5 (R = 0.35, p > 0.1). Thus, elevated expression of the 3,-actin gene results in Tm 5 levels remaining relatively unchanged. The observed morphological and cytoarchitectural similarities displayed after elevated expression of the 7-actin and the 3m gene also extend to the pattern of mRNA expression of different tropomyosin isoforms. The impact of elevated expression of the Bsm gene on the levels of tropomyosin isoform mRNAs is illustrated in Fig. 8, C Figure 8 . Expression of nonmuscle tropomyosin mRNAs in the 7-and/~sm-actin transfectants. Total cellular RNA was isolated from four 7-and four B~m-actin transfectants and analyzed as described in Fig. 7 . Graphs A and B correspond to 7-actin transfectants and graphs C and D to 3,m-actin transfectants. Linear regression analysis was performed on the data points and the resulting line is shown on each graph. expression has no impact on Tm 5 expression (R = 0.61, p > 0.1). Once again these results correlate with the immunofluorescence staining intensity (Fig. 5) and protein levels of Tm 2 (Fig. 6, lane 2) . In general, the pattern of tropomyosin gene expression observed in the 3,m transfectants corresponds to that observed in the 7-actin transfectants.
In summary, the results presented show that C2 myoblasts which display distinct morphologies and cytoarchitectures due to changes in the relative expression of nonmuscle actin genes, differentially regulate tropomyosin isoforms at the transcript and protein levels. Most importantly, different tropomyosin isoforms respond differently, strongly suggesting functional differences among the tropomyosin isoforms. Furthermore, elevated expression of two distinct actin genes previously shown to elicit (a) similar changes in morphology and actin cable organization , and (b) a similar pattern of expression of the endogenous actin genes were also shown to have a similar impact on the pattern of expression of the tropomyosin isoforms. These observations suggest that a similar mechanism might be operating to regulate tropomyosin expression in response to morphological and cytoarchitectural changes arising from the impact of two different actin genes.
Discussion Evidence for a Dynamic Equilibrium between Cytoskeletal Gene Expression and Changes in Cell Shape
The studies presented in this paper strongly suggest that alThe Journal of Cell Biology, Volume 121, 1993tering cell shape by directly targeting the expression of a major cytoskeletal component, actin, can ultimately lead to changes in the expression of other components that constitute the cell cytoskeleton. Hence, elevated expression of two distinct actin genes 3'-and/3~, previously shown to elicit similar changes in cell morphology and actin cable organization , were also shown to give rise to similar changes in tropomyosin organization and gene expression. Thus, at the transcript level, a decrease in the expression of the Tm 2, 3 gene products was observed, whereas the mRNA levels of Tm 5 remained relatively unchanged.
The distinct pattern of tropomyosin gene expression observed in these actin transfectants was also found to correlate with the distinct cellular organization of these two tropomyosin isoforms. The 3"-and B,,-actin transfectants were found to exhibit a decrease in the intensity of staining and diffuse organization of Tm 2 which parallels with the significant decrease in Tm 2 expression at both the protein and transcript levels. The well-defined stress fiber-like organization and similar staining intensity of Tm 5 is in agreement with no significant changes found in the expression of this isoform. Additionally, elevated expression of the/~,,-gene, known to alter morphology and actin cable organization in a manner distinct from elevated 3'-and B~m gene expression, was also found to result in a different pattern of tropomyosin gene expression to that observed in the 3'-and /~m transfectants. Additional evidence to support the observed coordinated regulation of cell shape and cytoskeletal gene expression is provided by the work of Leavitt et al. (1987a,b) . In their experiment, the stable transfection of the B,=-actin gene into human KD fibroblasts lead to cell shape changes coupled with a significant decrease in the protein synthesis of Tm 1, 2 and 3, whereas Tm 4 and 5 were less affected. Together these experiments provide evidence to support a dynamic equilibrium between changes in actin gene expression and tropomyosin organization and gene expression.
A Feedback Regulatory Mechanism May Control Tropomyosin Gene Expression
The present study together with that described in Schevzov et al. (1992) suggests that the observed changes in tropomyosin organization and gene expression described above may be influenced by the actin composition of the microfilaments. Previously reported studies have shown that the aberrant Bsm protein is impaired in its ability to form filaments. It does however form dimers that can assemble into bundle-like structures (Milloning et al., 1988) . A total of 80% of the actin present in the ~s~, transfectants consists of the #~ protein . Therefore, the inability of the/3,m protein to form proper filaments may render the filaments incapable of interacting with the high Mr tropomyosin isoforms. The failure of Tm 2 to segregate into the preexisting stress fibers may result in the downregulation of Tm 2 both at the mRNA and protein levels. The similar observations made in the 3'-actin transfectants in terms of the actin and tropomyosin organization strengthen this hypothesis. In this case, elevated expression of the 3'-actin gene (0.3/~:3" mRNA and protein ratio, Schevzov et al., 1992) most likely leads to actin filaments consisting predominantly of 3"-actin. These filaments may be dysfunctional like those present in the/3,m transfectants because similar changes in the expression and cellular organization of Tm 2 are observed. In contrast, no changes in the cellular organization and expression of Tm 5 were observed in these actin transfectants. It appears that Tm 5 preferentially segregates into filaments in all these cells suggesting that Tm 5 does not discriminate between different actin templates.
We propose two possible mechanisms by which the observed relationship between cytoarchitectural changes and cytoskeletal gene expression may take place. First, it is possible that different populations of actin filaments exist in the cell and some of these filaments have a better association with Tm 5 than others. In the/3~ and 3'-actin transfectants the Tm 5-associated filaments may not have been altered, with no consequent alterations in Tm 5 organization. Rather, a second class of filaments containing mainly the Tm 2 isoform would be predicted to be largely eliminated in the 3'-and B,~-actin transfectants. Such a mechanism may be unlikely to occur considering the findings of Lin and coworker (1986) . They report that immunoprecipitation of tropomyosin-containing actin filaments with isoform-specific tropomyosin antibodies precipitates all filaments. This suggests that different populations of actin filaments associated with specific tropomyosin isoforms are unlikely to be present. A second possible molecular mechanism that may account for the observed differential organization and expression of tropomyosin isoforms has been proposed to operate during myogenesis (Gunning et ai., 1990) . The model suggests that competition exists between isoforms of a particular cytoskeletal component for inclusion into cellular structures and that the level of gene expression is determined by the competitiveness of the individual isoforms. The observations presented in this study would support this model. In the case of the 3'-and fl~-actin transfectants, failure of Tm 2 to segregate into stress fibers is proposed to lead to the downregulation of this isoform. In contrast, the ability of Tin 5 to continue to segregate into stress fibers results in no change in the levels of Tm 5. These results are therefore consistent with a feedback regulatory mechanism where cellular demand for a particular structural protein can regulate the mRNA levels. For example, the findings by Weinberger et al. (1992) reveal that the induction and maintenance of the neuronal tropomyosins is dependent on morphological differentiation and the maintenance of the neuronal phenotype. Similar feedback regulatory mechanism have also been previously demonstrated for tubulin (Cleveland, 1989) and more recently for actin (Lloyd et ai,, 1992) .
Similar models have been previously proposed for the global autoregulation of the cytoskeleton by Ben-Ze'ev (for review see Ben-Ze'ev, 1991) . In these experiments cell shape changes induced by inhibiting cell-matrix and cell-cell contacts, stimulation with growth factors, cell differentiation, and transformation by either chemical carcinogens or tumor viruses were found to correlate with changes in the expression of a number of cytoskeletal components. Although such a correlation has been previously documented, the difference between those experiments and the ones presented in this manuscript is the manner in which the cytoskeletal alterations are induced. This is important in determining whether a direct causal relationship exists between changes in cell shape and the expression of cytoskeletal components or are the observed changes in gene expression initially induced by a different pathway that is independent of the cell cytoskeleton. Because of the complex manner in which information from the outside environment can be transmitted to the cell nucleus it may well be possible that changes in gene expression induced by the above methods can initially by-pass the cell cytoskeleton. A mechanism to explain how this may occur could involve a second messenger system and/or regulatory molecules that could directly influence gene expression independent of the cytoskeleton. In contrast, the manner in which we have induced cytoskeletal changes in the ¢22 cells was by directly influencing the expression of a major cytoskeletal component. We therefore postulate that the observed changes in morphology and/or cytoskeletal gene expression are a direct result of altering aetin gene expression. In summary, this apparent direct link between actin and tropomyosin expression presented in this manuscript suggests that nonpharrnacological signals originating in the cytoskeleton can regulate cytoarchitectural gene expression.
Different Tropomyosin Isoforms May Discriminate between/3-and 7-act/n
Our initial aim has been to understand the functional significance of different cytoskeletal isoforms. In our previous study we showed that elevated expression of/3-or 7-actin genes resulted in a reciprocal impact on myoblast shape and actin filament organization . In the present study we show that these actin transfectants display a differential organization and expression of tropomyosin isoforms. Hence, a possible mechanism by which/3-and T-actin may elicit the observed reciprocal changes in myoblast cytoarchitecture is by differential regulation of tropomyosin isoforms. In particular, ~actin may provide a better template for association with the high M, tropomyosins than ~,-actin. This would in turn promote stress fiber stability in /3-actin transfectants and undermine stability in the ~,-actin transfectants. Stress fiber stability would be seen as a major determinant of cell morphology which is consistent with the work of Liu and Bretscher (1989) in yeast.
The work of Leavitt et al. (Ng et al., 1988) further emphasizes the correlation between the decrease in the/3:-y ratio and downregulation in the synthesis of the high M, tropomyosin isoforms. In these experiments a decrease in the/3:'y ratio induced by overexpression of the 7-actin gene in HuT-14T cells resulted in a 36-65 % decrease in the protein synthesis of Tin 3 and to a lesser extent Tm I and 6. In contrast, increasing the/3:7 ratio had no impact on tropomyosin synthesis (Ng et al., 1988) . Thus, it may be suggested that in both myoblasts and transformed fibroblasts, the/3:~ ratio can influence tropomyosin synthesis.
The differential expression of tropomyosin isoforms implies that they are independently regulated and thus may be functionally distinct. These studies are supported in part by the work of Matsumura and Yamashiro- Matsumura (1985) where in vitro studies have shown differential affinities of tropomyosin isoforms for the actin filaments. In addition, immunofluorescence studies on normal cultured fibroblast ceils suggest a differential localization of tropomyosin isoforms (Lin et al., 1988) 
